13F-HR filed by SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 47 holding rows worth $569,734,207.
- Accession
- 0001104659-23-091467
- Filer
- CIK 1744967
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 47 entries on the cover page, a total value of $569,734,207 stated on the cover page (in dollars after the unit check, H1), rows summing to $569,734,207 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 5,161,888 | $198,319,737 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 4,519,361 | $77,055,105 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,256,022 | $47,150,860 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 4,598,828 | $34,675,163 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 8,459,314 | $21,994,216 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 613,921 | $19,412,182 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 967,527 | $15,944,845 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,458,875 | $12,604,680 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 308,151 | $12,122,660 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 2,780,261 | $11,426,873 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 599,274 | $10,301,520 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 202,773 | $9,420,834 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,675,579 | $7,791,442 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 347,500 | $7,346,150 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 696,171 | $7,219,293 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 640,688 | $7,086,009 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 470,304 | $6,889,954 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,868,035 | $6,280,997 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 651,050 | $5,820,387 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 345,293 | $5,693,882 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 80,963 | $4,854,541 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 396,000 | $4,569,840 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 360,414 | $4,278,114 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 432,000 | $3,758,400 | dollars as filed | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 801,629 | $3,086,272 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 881,450 | $2,776,568 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,034,552 | $2,441,462 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 196,425 | $2,345,315 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 630,000 | $2,091,600 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 1,008,437 | $1,971,494 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 602,203 | $1,884,895 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 202,348 | $1,770,545 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 154,664 | $1,427,549 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,049,153 | $1,342,916 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 830,565 | $1,262,459 | dollars as filed | |
| VTV THERAPEUTICS INC CL A | 918385105 | Stock | 1,635,509 | $1,209,950 | dollars as filed | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 1,788,280 | $985,342 | dollars as filed | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 689,709 | $972,490 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 172,089 | $750,308 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 883,720 | $398,116 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 82,336 | $279,942 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 25,000 | $208,250 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 900,000 | $191,250 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 21,244 | $157,843 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 78,131 | $134,385 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 133,333 | $22,052 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 99,999 | $5,520 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-091467 | this filing | 2023-08-14 | acceptance time not in the bulk data set |